癫痫杂志

癫痫杂志

癫痫患者的抑郁筛查工具:对已验证工具的系统评价

查看全文

抑郁影响约 25% 的癫痫患者。然而,癫痫中筛查抑郁的最佳工具尚未明确。研究的目的是系统筛查关于抑郁筛查工具在癫痫中有效性的文献。搜索MEDLINE、EMBASE 和 PsycINFO 数据库时间截至 2016 年 4 月 4 日,对国家或出版语言没有限制。摘要、全文筛查和数据提取由两名研究者进行。 纳入了在癫痫中评估抑郁筛查工具有效性,并报道了诊断准确性(例如,敏感性、特异性以及阴性和阳性预测值)的研究。使用诊断准确性研究的质量评估第 2 版评估研究质量。适当时,计算诊断准确性的估计中位数和范围。共筛选 16 070 篇摘要,其中 38 篇符合纳入标准。 16 种筛选工具在 13 种语言的文章中验证了。 最常用的筛查工具是神经系统疾病伴抑郁量表-供癫痫患者使用(Neurological disorders depression inventory for epilepsy,NDDI-E)(n=26)。简明国际神经精神访谈(Mini international neuropsychiatric interview,MINI)(n=19)是最常用的参考标准。在最常见的截点>15(n=12)中,NDDI-E 的中位灵敏度为 80.5%(范围 64.0~100.0),特异性为 86.2%(范围 81.0~95.6)。由于评估截点的多变性、参考标准的使用以及缺乏置信区间(CI)报告,Meta 分析不可行。许多研究证实了抑郁筛查工具,然而,关于诊断准确性的评估报道不一。在实践中,量表的有效性可能被高估了,因为截点常常是基于研究样本事后选择的。虽然,最佳工具的选择可能因使用环境和可用资源而异,但执行良好的 NDDI-E 是最常用的有效的筛查工具,它向公众免费开放,并经多种语言验证,且易于管理。

关键词: 严重抑郁; 心理健康; 共病; 诊断准确性; 测量

引用本文: Stephanie J.Gill, SaraLukmanji, Kirsten M.Fiest, 张乐 译, 熊维希 慕洁 审. 癫痫患者的抑郁筛查工具:对已验证工具的系统评价. 癫痫杂志, 2018, 4(5): 426-435. doi: 10.7507/2096-0247.20180071 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859): 2163-2196.
2. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia, 2007, 48(12): 2336-2344.
3. Fiest KM, Dykeman J, Patten SB, et al. Depression in epilepsy: a systematic review and meta-analysis. Neurology, 2013, 80(6): 590-599.
4. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med, 2000, 160(14): 2101-2107.
5. Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia, 2006, 47(11): 1915-1921.
6. Hesdorffer DC, Ishihara L, Webb DJ, et al. Occurrence and recurrence of attempted suicide among people with epilepsy. JAMA Psychiatry, 2016, 73(1): 80-86.
7. Boylan LS, Flint LA, Labovitz DL, et al. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology, 2004, 62(2): 258-261.
8. Fiest KM, Patten SB, Jette N. Screening for depression and anxiety in epilepsy. Neurol Clin, 2016, 34(2): 351-361.
9. Pettersson A, Bostrom KB, Gustavsson P, et al. Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review. Nord J Psychiatry, 2015, 69(7): 497-508.
10. Lakkis NA, Mahmassani DM. Screening instruments for depression in primary care: a concise review for clinicians. Postgrad Med, 2015, 127(1): 99-106.
11. Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol, 2006, 5(5): 399-405.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 2009, 339: b2535.
13. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
14. Al-Asmi A, Dorvlo AS, Burke DT, et al. The detection of mood and anxiety in people with epilepsy using two-phase designs: experiences from a tertiary care centre in oman. Epilepsy Res, 2012, 98(2-3): 174-181.
15. Alkhamees HA, Selai CE, Shorvon SD, et al. The use of the NDDI-E in arabic to identify symptoms of depression of moderate or greater severity in people with epilepsy. Epilepsy Behav, 2014, 32: 55-58.
16. Botega NJ, Ponde MP, Medeiros P, et al. Validation of the hospital anxiety and depression scale in ambulatory epileptic patients. J Bras Psiquiatr, 1998, 47: 285-289.
17. Brandt C, Labudda K, Illies D, et al. Rapid detection of a depressive disorder in persons with epilepsy. Validation of a german version of the NDDI-E. Nervenarzt, 2014, 85(9): 1151-1155.
18. de Lemos Zingano B, Guarnieri R, Diaz AP, et al. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy. Epilepsy Behav, 2015, 50: 61-66.
19. de Oliveira GN, Kummer A, Salgado JV, et al. Brazilian version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2010, 19(3): 328-331.
20. de Oliveira GN, Lessa JM, Goncalves AP, et al. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and beck depression inventory (BDI). Epilepsy Behav, 2014, 34: 50-54.
21. de Oliveira GNM, de Araujo Filho GM, Kummer A, et al. Beck depression inventory (BDI) and hamilton rating scale for depression (HAM-D) in patients with epilepsy. J Bras Psiquiatr, 2011, 60: 131-134.
22. De Oliveira GNM, De Araujo Filho GM, Kummer A, et al. Neurological disorders depression inventory for epilepsy (NDDI-E): Brazilian version of a screening instrument [Portuguese]. JECN, 2011, 17: 49-53.
23. Di Capua D, Garcia-Garcia ME, Reig-Ferrer A, et al. Validation of the spanish version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 24(4): 493-496.
24. Drinovac M, Wagner H, Agrawal N, et al. Screening for depression in epilepsy: a model of an enhanced screening tool. Epilepsy Behav, 2015, 44: 67-72.
25. Fiest KM, Patten SB, Wiebe S, et al. Validating screening tools for depression in epilepsy. Epilepsia, 2014, 55(10): 1642-1650.
26. Friedman DE, Kung DH, Laowattana S, et al. Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening. Seizure, 2009, 18(6): 429-433.
27. Gandy M, Sharpe L, Perry KN, et al. Assessing the efficacy of 2 screening measures for depression in people with epilepsy. Neurology, 2012, 79(4): 371-375.
28. Gross DW, Davies M, Jirsch JD, et al. Screening for depression in a tertiary epilepsy clinic. Can J Neurol Sci, 2014, 41(4): 525-527.
29. Guo Y, Chen ZM, Zhang YX, et al. Reliability and validity of the chinese version of the neurological disorders depression inventory for epilepsy (C-NDDI-E). Epilepsy Behav, 2015, 45: 225-228.
30. Hansen CP, Amiri M. Combined detection of depression and anxiety in epilepsy patients using the neurological disorders depression inventory for epilepsy and the world health organization well-being index. Seizure, 2015, 33: 41-45.
31. Hesdorffer DC, Baldin E, Caplan R, et al. How do we measure psychiatric diagnoses? Implications of the choice of instruments in epilepsy. Epilepsy Behav, 2014, 31: 351-355.
32. Jones JE, Hermann BP, Woodard JL, et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia, 2005, 46(5): 731-735.
33. Karzmark P, Zeifert P, Barry J. Measurement of depression in epilepsy. Epilepsy Behav, 2001, 2(2): 124-128.
34. Ko PW, Hwang J, Lim HW, et al. Reliability and validity of the Korean version of the neurological disorders depression inventory for epilepsy (K-NDDI-E). Epilepsy Behav, 2012, 25(4): 539-542.
35. Margrove K, Mensah S, Thapar A, et al. Depression screening for patients with epilepsy in a primary care setting using the patient health questionnaire-2 and the neurological disorders depression inventory for epilepsy. Epilepsy Behav, 2011, 21(4): 387-390.
36. Mbewe EK, Uys LR, Nkwanyana NM, et al. A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in zambia. Epilepsy Behav, 2013, 27(2): 296-300.
37. Metternich B, Wagner K, Buschmann F, et al. Validation of a german version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 25(4): 485-488.
38. Micoulaud-Franchi JA, Barkate G, Trebuchon-Da Fonseca A, et al. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the french NDDI-E. Epilepsy Behav, 2015, 44: 11-16.
39. Mitchell AJ, Ioannou N, Rampling JM, et al. Which symptoms are indicative of depression in epilepsy settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord, 2013, 150(3): 861-867.
40. Mula M, Iudice A, La Neve A, et al. Validation of the italian version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 24(3): 329-331.
41. Mula M, Iudice A, La Neve A, et al. Validation of the hamilton rating scale for depression in adults with epilepsy. Epilepsy Behav, 2014, 41: 122-125.
42. Rampling J, Mitchell AJ, Von Oertzen T, et al. Screening for depression in epilepsy clinics. A comparison of conventional and visual-analog methods. Epilepsia, 2012, 53(10): 1713-1721.
43. Rathore JS, Jehi LE, Fan Y, et al. Validation of the patient healthquestionnaire-9 (PHQ-9) for depression screening in adults with epilepsy. Epilepsy Behav, 2014, 37: 215-220.
44. Ristic AJ, Pjevalica J, Trajkovic G, et al. Validation of the neurological disorders depression inventory for epilepsy (NDDI-E) serbian version. Epilepsy Behav, 2016, 57(Part A): 1-4.
45. Tadokoro Y, Oshima T, Fukuchi T, et al. Screening for major depressive episodes in japanese patients with epilepsy: validation and translation of the Japanese version of neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2012, 25(1): 18-22.
46. Thomson AE, Calle A, Fontela ME, et al. Screening of major depression in epilepsy: the neurologic depression disorders inventory in epilepsy-spanish version (Argentina). Epilepsia, 2014, 55(2): 331-334.
47. Tong X, An D, Lan L, et al. Validation of the chinese version of the neurological disorders depression inventory for epilepsy (C-NDDIE) in West China. Epilepsy Behav, 2015, 47: 6-10.
48. Wagner JL, Smith G, Ferguson PL, et al. Preliminary psychometrics of the neurological disorders depression inventory for epilepsy-youth. J Child Neurol, 2013, 28(11): 1392-1399.
49. Walker ER, Engelhard G Jr, Thompson NJ. Using rasch measurement theory to assess three depression scales among adults with epilepsy. Seizure, 2012, 21(6): 437-443.
50. Zis P, Yfanti P, Siatouni A, et al. Validation of the greek version of the neurological disorders depression inventory for epilepsy (NDDI-E). Epilepsy Behav, 2013, 29(3): 513-515.
51. Egger M, Davey-Smith G, Altman D. Systematic reviews in health care: meta-analysis in context. London: John Wiley & Sons, 2008.
52. Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale. an updated literature review. J Psychosom Res, 2002, 52(2): 69-77.
53. Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed), 1986, 292(6516): 344.
54. Brislin RW. Back-translation for cross-cultural research. J Cross Cult Psychol, 1970, 1: 185-216.
55. Jones JE, Hermann BP, Barry JJ, et al. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci, 2005, 17(2): 172-179.
56. Sanchez-Villegas A, Schlatter J, Ortuno F, et al. Validity of a selfreported diagnosis of depression among participants in a cohort study using the structured clinical interview for DSM-IV (SCID-I). BMC Psychiatry, 2008, 8: 43.
57. Jones JE, Austin JK, Caplan R, et al. Psychiatric disorders in children and adolescents who have epilepsy. Pediatr Rev, 2008, 29(2): e9-e14.
58. Guilfoyle SM, Monahan S, Wesolowski C, et al. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection. Epilepsy Behav, 2015, 44: 5-10.
59. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin Chem, 2015, 61(12): 1446-1452.
60. Thombs BD, Benedetti A, Kloda LA, et al. Diagnostic accuracy of the edinburgh postnatal depression scale (EPDS) for detecting major depression in pregnant and postnatal women: protocol for a systematic review and individual patient data meta-analyses. BMJ Open, 2015, 5(10): e009742.
61. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry, 1961, 4: 561-571.
62. Dori GA, Overholser JC. Evaluating depression severity and remission with a modified beck depression inventory. Pers Individ Dif, 2000, 28: 1045-1061.
63. Kliem S, Mößle T, Zenger M, et al. Reliability and validity of the beck depression inventory-fast screen for medical patients in the general german population. J Affect Disord, 2014, 156: 236-239.
64. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand, 1983, 67(6): 361-370.
65. Mitchell AJ, Baker-Glenn EA, Granger L, et al. Can the distress thermometer be improved by additional mood domains? Part I. Initial validation of the emotion thermometers tool. Psychooncology, 2010, 19(2): 125-133.
66. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 2001, 16(9): 606-613.
67. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care, 2003, 41(11): 1284-1292.
68. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry, 1960, 23: 56-62.
69. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas, 1977, 1: 385-401.
70. Achenbach T. Child Behavior Checklist. In Kreutzer JS, DeLuca J, Caplan B (Eds) Encyclopedia of clinical neuropsychology. New York: Springer, 2011: 546-552.
71. Bech P. Clinical psychometrics. Oxford: John Wiley & Sons, 2012.
72. Butcher JN. Minnesota Multiphasic Personality Inventory-2: Manual for administration, scoring, and interpretation. Minneapolis, MN: University of Minnesota Press, 2001.